129 related articles for article (PubMed ID: 12804852)
21. The Pfs230 N-terminal fragment, Pfs230D1+: expression and characterization of a potential malaria transmission-blocking vaccine candidate.
Lee SM; Wu Y; Hickey JM; Miura K; Whitaker N; Joshi SB; Volkin DB; Richter King C; Plieskatt J
Malar J; 2019 Nov; 18(1):356. PubMed ID: 31703583
[TBL] [Abstract][Full Text] [Related]
22. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.
Narum DL; Kumar S; Rogers WO; Fuhrmann SR; Liang H; Oakley M; Taye A; Sim BK; Hoffman SL
Infect Immun; 2001 Dec; 69(12):7250-3. PubMed ID: 11705894
[TBL] [Abstract][Full Text] [Related]
23. A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.
Prieur E; Gilbert SC; Schneider J; Moore AC; Sheu EG; Goonetilleke N; Robson KJ; Hill AV
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):290-5. PubMed ID: 14694197
[TBL] [Abstract][Full Text] [Related]
24. DNA immunization with Plasmodium falciparum serine repeat antigen: regulation of humoral immune response by coinoculation of cytokine expression plasmid.
Sakai T; Horii T; Hisaeda H; Zhang M; Ishii K; Nakano Y; Maekawa Y; Izumi K; Nitta Y; Miyazaki J; Himeno K
Parasitol Int; 1999 Mar; 48(1):27-33. PubMed ID: 11269323
[TBL] [Abstract][Full Text] [Related]
25. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
Rainczuk A; Scorza T; Spithill TW; Smooker PM
Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
[TBL] [Abstract][Full Text] [Related]
26. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
28. Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission.
Kapoor N; Vanjak I; Rozzelle J; Berges A; Chan W; Yin G; Tran C; Sato AK; Steiner AR; Pham TP; Birkett AJ; Long CA; Fairman J; Miura K
Biochemistry; 2018 Feb; 57(5):516-519. PubMed ID: 29323879
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
30. Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes.
Williamson KC; Keister DB; Muratova O; Kaslow DC
Mol Biochem Parasitol; 1995 Dec; 75(1):33-42. PubMed ID: 8720173
[TBL] [Abstract][Full Text] [Related]
31. Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif.
Bruna-Romero O; Rocha CD; Tsuji M; Gazzinelli RT
Vaccine; 2004 Sep; 22(27-28):3575-84. PubMed ID: 15315836
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
33. Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity.
Regis DP; Dobaño C; Quiñones-Olson P; Liang X; Graber NL; Stefaniak ME; Campo JJ; Carucci DJ; Roth DA; He H; Felgner PL; Doolan DL
Mol Biochem Parasitol; 2008 Mar; 158(1):32-45. PubMed ID: 18164079
[TBL] [Abstract][Full Text] [Related]
34. Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination.
Shuaibu MN; Kikuchi M; Cherif MS; Helegbe GK; Yanagi T; Hirayama K
Vaccine; 2010 Oct; 28(42):6868-75. PubMed ID: 20709002
[TBL] [Abstract][Full Text] [Related]
35. Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African
Muthui MK; Kamau A; Bousema T; Blagborough AM; Bejon P; Kapulu MC
Front Immunol; 2019; 10():2480. PubMed ID: 31695697
[No Abstract] [Full Text] [Related]
36. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
[TBL] [Abstract][Full Text] [Related]
37. Passive immunoprotection of Plasmodium falciparum-infected mice designates the CyRPA as candidate malaria vaccine antigen.
Dreyer AM; Matile H; Papastogiannidis P; Kamber J; Favuzza P; Voss TS; Wittlin S; Pluschke G
J Immunol; 2012 Jun; 188(12):6225-37. PubMed ID: 22593616
[TBL] [Abstract][Full Text] [Related]
38. Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice.
Haddad D; Liljeqvist S; Ståhl S; Andersson I; Perlmann P; Berzins K; Ahlborg N
FEMS Immunol Med Microbiol; 1997 Jul; 18(3):193-202. PubMed ID: 9271170
[TBL] [Abstract][Full Text] [Related]
39. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees.
Schneider J; Langermans JA; Gilbert SC; Blanchard TJ; Twigg S; Naitza S; Hannan CM; Aidoo M; Crisanti A; Robson KJ; Smith GL; Hill AV; Thomas AW
Vaccine; 2001 Sep; 19(32):4595-602. PubMed ID: 11535306
[TBL] [Abstract][Full Text] [Related]
40. Influence of glycosylphosphatidylinositol anchorage on the efficacy of DNA vaccines encoding Plasmodium yoelii merozoite surface protein 4/5.
Wang L; Kedzierski L; Schofield L; Coppel RL
Vaccine; 2005 Jul; 23(32):4120-7. PubMed ID: 15964480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
